Cancer Immunotherapy - A Global Market Overview

This global Cancer Immunotherapy report analyzes the market based on Product (Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines, Checkpoint Inhibitors & Immunomodulators), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Skin Cancer, Prostate Cancer, Stomach Cancer, Head & Neck Cancer, Others), End-User (Hospitals & Clinics, Cancer Research Centers, Other End-Users), and by geographic region (North America, Europe, Asia-Pacific, South America and Middle East & Africa for 2021-2030 period in terms of value in US$ million, projected from 2024 through 2030. The global market for Cancer Immunotherapy is estimated at US$135.2 billion in 2024 and is anticipated to post a CAGR of 9.8% during the 2024-2030 analysis period and stand at a projected US$236.9 billion by 2030.

本全球癌症免疫治疗市场分析报告基于产品（单克隆抗体、溶瘤病毒疗法及癌症疫苗、检查点抑制剂及免疫调节剂）、应用（肺癌、乳腺癌、结直肠癌、皮肤癌、前列腺癌、胃癌、头颈癌及其他）、终端用户（医院及诊所、癌症研究中心及其他终端用户）以及地理区域（北美、欧洲、亚太地区、南美以及中东及非洲）对2021-2030年期间的市场价值（以亿美元计）进行剖析，预测期从2024年延伸至2030年。全球癌症免疫治疗市场规模预计在2024年达到1352亿美元，预计在2024-2030年的分析期间实现9.8%的复合年增长率，并预计到2030年将达到2369亿美元。